Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
Department of Trauma Surgery, Klinikum Rechts der Isar, Munich, Germany.
Eur J Radiol. 2022 Jul;152:110360. doi: 10.1016/j.ejrad.2022.110360. Epub 2022 May 14.
To determine the response of hepatic tissue to percutaneous microwave ablation (MWA) of liver tumors via MR elastography in a clinical setting using MRI and MR elastography.
51 Patients (28 m, 23f) underwent MWA of liver tumors (HCC: 20, metastasis: 31) and received MRI and MR elastography immediately before and 24 h after MWA. Retrospective analysis included pre- and post-ablative tumor extent, T1/T2 mapping and stiffness values as well as the duration and energy dose of the MWA session.
Total liver stiffness increased by 4.3% from 3.31 kPa to 3.45 kPa (p = 0.036). Total liver stiffness post-MWA significantly correlated with the duration of the MWA session (r = 0.369, p = 0.008). The higher the baseline tumor stiffness was, the more energy had to be applied in MWA (r = 0.391, p < 0.001) and the longer the duration of the session (r = 0.391, p = 0.007). Healthy parenchyma stiffness increased by 3.5% from 3.55 kPa to 3.68 kPa (p = 0.142) and was strongly influenced by the cumulative energy (r = 0.436, p < 0.001), the duration (r = 0.458, p < 0.001) and the energy intensity (r = 0.458, p < 0.001) of MWA. 43 patients had a technically successful ablation result (margin ≥ 5 mm). Those with successful ablation had increased ablation margin stiffness (5.3 kPa vs. 4.6 kPa, p = 0.26) and had received higher ablation intensity than those with unsuccessful ablation (5.73 kJ/min vs. 5.03 kJ/min, p = 0.002).
Additional MRE may be used before and after MWA to assess treatment response and collateral tissue damage after MWA. Baseline tumor stiffness helps finding the appropriate MWA parameters.
通过 MRI 和磁共振弹性成像(MRE),在临床环境中使用微波消融(MWA)治疗肝脏肿瘤,确定肝组织对 MWA 的反应。
51 例患者(28 例男性,23 例女性)接受了肝脏肿瘤的 MWA(HCC:20 例,转移瘤:31 例),并在 MWA 前后 24 小时接受 MRI 和 MRE。回顾性分析包括消融前和消融后的肿瘤范围、T1/T2 图谱和硬度值以及 MWA 疗程的持续时间和能量剂量。
总肝硬度从 3.31kPa 增加到 3.45kPa(p=0.036),增加了 4.3%。MWA 后总肝硬度与 MWA 疗程的持续时间显著相关(r=0.369,p=0.008)。基线肿瘤硬度越高,MWA 所需的能量越高(r=0.391,p<0.001),疗程持续时间越长(r=0.391,p=0.007)。健康肝实质硬度从 3.55kPa 增加到 3.68kPa(p=0.142),增加了 3.5%,并受到累积能量(r=0.436,p<0.001)、疗程(r=0.458,p<0.001)和能量强度(r=0.458,p<0.001)的强烈影响。43 例患者的消融技术成功(边缘≥5mm)。消融成功的患者消融边缘硬度增加(5.3kPa 与 4.6kPa,p=0.26),且消融强度高于消融不成功的患者(5.73kJ/min 与 5.03kJ/min,p=0.002)。
MWA 前后可额外使用 MRE 评估 MWA 治疗反应和 MWA 后 collateral 组织损伤。基线肿瘤硬度有助于确定适当的 MWA 参数。